1h Free Analyst Time
The publisher has been monitoring the bone cancer drugs market and it is poised to grow by USD 996.69 mn during 2021-2025, progressing at a CAGR of 5.46% during the forecast period. The report on the bone cancer drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by strong prevalence of osteosarcoma in younger patients and growing risk factors.
The bone cancer drugs market analysis includes the indication segment and geographic landscape.
The bone cancer drugs market is segmented as below:
By Indication
- Osteosarcoma
- Ewing's sarcoma
- Chondrosarcoma
- Other bone cancers
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the increasing strategic alliances as one of the prime reasons driving the bone cancer drugs market growth during the next few years.
The report on bone cancer drugs market covers the following areas:
- Bone cancer drugs market sizing
- Bone cancer drugs market forecast
- Bone cancer drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bone cancer drugs market vendors that include Amgen Inc., Baxter International Inc., Bayer AG, Bristol-Myers Squibb Co., Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., Merck and Co. Inc., Novartis AG, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. Also, the bone cancer drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Indication
- Market segments
- Comparison by Indication
- Osteosarcoma - Market size and forecast 2020-2025
- Ewing's sarcoma - Market size and forecast 2020-2025
- Chondrosarcoma - Market size and forecast 2020-2025
- Other bone cancers - Market size and forecast 2020-2025
- Market opportunity by Indication
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Amgen Inc.
- Baxter International Inc.
- Bayer AG
- Bristol-Myers Squibb Co.
- Eisai Co. Ltd.
- F. Hoffmann-La Roche Ltd.
- Merck and Co. Inc.
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2020 - 2025 ($ million)
- Global market: Year-over-year growth 2020 - 2025 (%)
- Five forces analysis 2020 & 2025
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2020
- Other1 - Market share 2020-2025 (%)
- Comparison by Other1
- Osteosarcoma - Market size and forecast 2020-2025 ($ million)
- Osteosarcoma - Year-over-year growth 2020-2025 (%)
- Chondrosarcoma - Market size and forecast 2020-2025 ($ million)
- Chondrosarcoma - Year-over-year growth 2020-2025 (%)
- Other bone cancers - Market size and forecast 2020-2025 ($ million)
- Other bone cancers - Year-over-year growth 2020-2025 (%)
- Market opportunity by Other1
- Customer landscape
- Market share By Geographical Landscape 2020-2025 (%)
- Geographic comparison
- North America - Market size and forecast 2020-2025 ($ million)
- North America - Year-over-year growth 2020-2025 (%)
- Europe - Market size and forecast 2020-2025 ($ million)
- Europe - Year-over-year growth 2020-2025 (%)
- Asia - Market size and forecast 2020-2025 ($ million)
- Asia - Year-over-year growth 2020-2025 (%)
- ROW - Market size and forecast 2020-2025 ($ million)
- ROW - Year-over-year growth 2020-2025 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Amgen Inc. - Overview
- Amgen Inc. - Business segments
- Amgen Inc. - Key offerings
- Amgen Inc. - Key customers
- Amgen Inc. - Segment focus
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Key customers
- Baxter International Inc. - Segment focus
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key offerings
- Bayer AG - Key customers
- Bayer AG - Segment focus
- Bristol-Myers Squibb Co. - Overview
- Bristol-Myers Squibb Co. - Product and service
- Bristol-Myers Squibb Co. - Key offerings
- Bristol-Myers Squibb Co. - Key customers
- Bristol-Myers Squibb Co. - Segment focus
- Eisai Co. Ltd. - Overview
- Eisai Co. Ltd. - Business segments
- Eisai Co. Ltd. - Key offerings
- Eisai Co. Ltd. - Key customers
- Eisai Co. Ltd. - Segment focus
- F. Hoffmann-La Roche Ltd. - Overview
- F. Hoffmann-La Roche Ltd. - Business segments
- F. Hoffmann-La Roche Ltd. - Key offerings
- F. Hoffmann-La Roche Ltd. - Key customers
- F. Hoffmann-La Roche Ltd. - Segment focus
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Key customers
- Merck and Co. Inc. - Segment focus
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key offerings
- Novartis AG - Key customers
- Novartis AG - Segment focus
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Business segments
- Sun Pharmaceutical Industries Ltd. - Key offerings
- Sun Pharmaceutical Industries Ltd. - Key customers
- Sun Pharmaceutical Industries Ltd. - Segment focus
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Key customers
- Teva Pharmaceutical Industries Ltd. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global bone cancer drugs market: Amgen Inc., Baxter International Inc., Bayer AG, Bristol-Myers Squibb Co., Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., Merck and Co. Inc., Novartis AG, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing strategic alliances.`
According to the report, one of the major drivers for this market is the strong prevalence of osteosarcoma in younger patients.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amgen Inc.
- Baxter International Inc.
- Bayer AG
- Bristol-Myers Squibb Co.
- Eisai Co. Ltd.
- F. Hoffmann-La Roche Ltd.
- Merck and Co. Inc.
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
